US 7445794
Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 7445794 (Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors) held by The Regents of the University of Colorado expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K39/3955